Are the benefits of new cancer drugs worth the cost?
by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef
Updated on: January 12,2024
10

Are the benefits of new cancer drugs worth the cost?
by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef
Updated on:January 12,2024
10
